Engagement with Medication Among Kidney Transplant Recipients - A Descriptive Cross-Sectional Study

Engagement with Medication Among Kidney Transplant Recipients - A Descriptive Cross-Sectional Study


Identification: nnj_jf_19A5
Issue: January-February 2019
Volume: Vol. 46, No. 1
Credits (Post Test and/or Evaluation Required)
Available until 03/01/2021
  • 1.30 - CH

Standard: $30.00

Description

Contact hours available until 2/28/21.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation.

Nephrology Nursing Journal Editorial Board Statements of Disclosure:

In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.

Paula Dutka, MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.

Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.

Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a member of the ANNA Board of Directors, serves on the Scientific Advisory Board for Kibow Biotech, Inc., and is employed by Fresenius Kidney Care as an acute hemodialysis RN.

All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.

This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.

Learning Outcome:

After completing this learning activity, the learner will be able to discuss the level of engagement with medication among kidney transplant recipients in South Africa.

Learner Engagement Activity:

For a different aspect on this topic, view the session, “Management of the Older Transplant Recipient,” presented by Mara McAdams-Demarco, PhD, at the 2017 ANNA National Symposium: Click Here! (Additional costs may be associated)

Author(s)

Credits Available


Engagement with Medication Among Kidney Transplant Recipients - A Descriptive Cross-Sectional Study

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content